PRE 14A

Proxy Statement (Preliminary)

Protalix BioTherapeutics, Inc. Filed 2019-10-04 Acc 0001144204-19-047387

Documents 1

PRE 14A Proxy Statement (Preliminary) , tv530595_pre14a.htm

Around this filing

2021-09-17 PRE 14A Proxy Statement (Preliminary)
2019-10-04 PRE 14A Proxy Statement (Preliminary)
2018-10-05 PRE 14A Proxy Statement (Preliminary)

Link to a passage

External

SEC EDGAR (opens in new tab)